The test determines the fetal RhD genotype, which can influence prenatal care protocols, thereby preventing RhD-negative mothers from receiving anti-D blood products unnecessarily. The test is recommended for all RhD-negative pregnant women with a gestational age of at least 10 weeks and an RhD-positive partner.

This test detects specific sequences in exons 5 and 7 of the RHD gene using real-time PCR (Real-Time Polymerase Chain Reaction)

The genetic test involves analyzing fetal DNA circulating in the mother’s blood and is performed on a blood sample taken from the pregnant woman starting at the 10th week of pregnancy.

Results in 13 working days.